57 related articles for article (PubMed ID: 12691143)
1. Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment.
Borcherding N; Severson KJ; Henderson N; Ortolan LS; Rosenthal AC; Bellizzi AM; Liu V; Link BK; Mangold AR; Jabbari A
Blood Adv; 2023 Feb; 7(3):321-335. PubMed ID: 35390145
[TBL] [Abstract][Full Text] [Related]
2. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
Gao J; Ren S; Choonoo G; Chen G; Frleta D; Zhong J; Gupta N; Sharma P; Oyejide A; Atwal GS; Macdonald L; Murphy A; Kuhnert F
Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37718909
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
Preston JD; Jansen CS; Kosaraju S; Niyogusaba T; Zhuang TZ; Iwamoto SW; Hutto SK; Lechowicz MJ; Allen PB
CNS Oncol; 2023 Dec; 12(4):CNS105. PubMed ID: 37877303
[TBL] [Abstract][Full Text] [Related]
4. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.
Kari L; Loboda A; Nebozhyn M; Rook AH; Vonderheid EC; Nichols C; Virok D; Chang C; Horng WH; Johnston J; Wysocka M; Showe MK; Showe LC
J Exp Med; 2003 Jun; 197(11):1477-88. PubMed ID: 12782714
[TBL] [Abstract][Full Text] [Related]
5. FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes.
Avery J; Kim SR; Cheng W; Foss F; Girardi M
JID Innov; 2023 Sep; 3(5):100212. PubMed ID: 37674691
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
7. The biomarker landscape in mycosis fungoides and Sézary syndrome.
Dulmage B; Geskin L; Guitart J; Akilov OE
Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors.
Pulitzer M; Myskowski PL; Horwitz SM; Querfeld C; Connolly B; Li J; Murali R
Pathology; 2014 Dec; 46(7):610-6. PubMed ID: 25393251
[TBL] [Abstract][Full Text] [Related]
9. The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.
Scala E; Abeni D; Pomponi D; Narducci MG; Lombardo GA; Mari A; Frontani M; Picchio MC; Pilla MA; Caprini E; Russo G
Haematologica; 2010 Nov; 95(11):1905-12. PubMed ID: 20663947
[TBL] [Abstract][Full Text] [Related]
10. Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.
Capriotti E; Vonderheid EC; Thoburn CJ; Wasik MA; Bahler DW; Hess AD
Leuk Lymphoma; 2008 Jun; 49(6):1190-201. PubMed ID: 18569641
[TBL] [Abstract][Full Text] [Related]
11. Receptor-directed therapy of T-cell leukemias and lymphomas.
Morris JC; Waldmann TA; Janik JE
J Immunotoxicol; 2008 Apr; 5(2):235-48. PubMed ID: 18569395
[TBL] [Abstract][Full Text] [Related]
12. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
13. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell lymphoma. Refinement in the application of controversial histologic criteria.
Glusac EJ; Shapiro PE; McNiff JM
Dermatol Clin; 1999 Jul; 17(3):601-14, ix. PubMed ID: 10410861
[TBL] [Abstract][Full Text] [Related]
16. Sézary syndrome and related variants of classic cutaneous T-cell lymphoma. A descriptive and prognostic clinicopathologic study of 29 cases.
Marti RM; Pujol RM; Servitje O; Palou J; Romagosa V; Bordes R; González-Castro J; Miralles J; Gallardo F; Curcó N; Gómez X; Domingo A; Estrach T
Leuk Lymphoma; 2003 Jan; 44(1):59-69. PubMed ID: 12691143
[TBL] [Abstract][Full Text] [Related]
17. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.
Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R
Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
